626 related articles for article (PubMed ID: 11859600)
1. Postmenopausal hormone replacement therapy: does the progestin make a difference?
Fylstra DL
J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
[No Abstract] [Full Text] [Related]
2. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
Rollins G
Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
[No Abstract] [Full Text] [Related]
3. Hormone replacement therapy: estrogen after menopause.
Gibaldi M
Pharmacotherapy; 1996; 16(3):366-75. PubMed ID: 8726594
[No Abstract] [Full Text] [Related]
4. HRT dosing regimens: continuous versus cyclic-pros and cons.
Shoupe D
Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
[TBL] [Abstract][Full Text] [Related]
5. Vaginal bleeding patterns in women receiving hormone replacement therapy. Impact of various progestogen regimens.
Thorneycroft IH; Gibbons WE
J Reprod Med; 1999 Feb; 44(2 Suppl):209-14. PubMed ID: 11392034
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal hormone therapy and breast cancer.
Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy and the menopause. Australian Menopause Society.
MacLennan AH
Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437
[No Abstract] [Full Text] [Related]
8. Where are we with postmenopausal hormone therapy in 2005?
Lam PM; Chung TK; Haines C
Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal estrogen and cardiovascular disease.
Stampfer MJ; Grodstein F; Bechtel S
Contemp Intern Med; 1994 Sep; 6(9):47-56, 59. PubMed ID: 10150308
[TBL] [Abstract][Full Text] [Related]
10. [Postmenopausal hormone replacement therapy and cardiovascular disease].
Høibraaten E
Tidsskr Nor Laegeforen; 2002 Jun; 122(16):1564-5. PubMed ID: 12119783
[No Abstract] [Full Text] [Related]
11. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
12. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
Emons G; Westphalen S
MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
[TBL] [Abstract][Full Text] [Related]
13. [Postmenopausal estrogen therapy: pharmacological treatment or replacement of the lacking hormone?].
Lippert TH; Seeger H; Mueck AO
Dtsch Med Wochenschr; 1999 Oct; 124(42):1245-8. PubMed ID: 10572534
[No Abstract] [Full Text] [Related]
14. Breast cancer risk during hormone therapy: experimental versus clinical data.
Ruan X; Seeger H; Mueck AO
Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and progestogen therapy in postmenopausal women.
Practice Committee of American Society for Reproductive Medicine
Fertil Steril; 2008 Nov; 90(5 Suppl):S88-102. PubMed ID: 19007655
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
Calleja-Agius J; Brincat MP
Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
[TBL] [Abstract][Full Text] [Related]
17. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
[TBL] [Abstract][Full Text] [Related]
18. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
von Schoultz B
Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
[No Abstract] [Full Text] [Related]
19. The case for postmenopausal hormone therapy.
Speroff L
Hosp Pract (1995); 1996 Feb; 31(2):75-89. PubMed ID: 8592021
[TBL] [Abstract][Full Text] [Related]
20. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
